Saturday 7 November 2026 Export AMRX’s income statement to Excel — free account

AMNEAL PHARMACEUTICALS, INC.

AMRX Healthcare Drug Manufacturers Specialty & Generic

AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.

Revenue: +9.96%
EPS: +267.0%
Free cash flow: −50.9%
Total debt: +23.8%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

20.11 0.66 +3.39%

Follow AMRX

Alert me

Market cap: $6.8B
P/E: 38.2×
Fwd P/E: 44.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.94
Beneish M: −2.68
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	6	7	7	7	+8 more TTM periods Free account
ROE Full definition →	(53,107.17%)	(395.84%)	(137.24%)	(79.69%)
ROA Full definition →	3.01%	4.37%	3.54%	2.01%
ROIC Full definition →	8.45%	11.05%	11.44%	11.25%
Return on Tangible Assets Full definition →	8.61%	10.35%	8.06%	4.89%
Average Days of Receivables Full definition →	116.35	119.51	102.02	108.29
Free Cash Flow per Share Full definition →	(0.18)	(0.04)	0.60	0.73
Free Cash Flow Full definition →	(60.46)	(11.59)	189.67	227.73
Capital Expenditures Full definition →	(241.09)	(212.37)	(116.17)	(112.26)
Other line items
Cash ROIC Full definition →	(1.56%)	(0.41%)	6.82%	8.10%
Accounts Receivable Turnover Full definition →	3.35	3.41	3.79	3.61
Accounts Payable Turnover Full definition →	2.51	2.73	2.89	2.55
Inventory Turnover Full definition →	2.89	2.94	3.01	3.13
Average Days of Payables Full definition →	150.76	139.15	129.52	145.83
Days of Inventory on Hand Full definition →	135.30	130.81	125.35	116.14
Tax Rate Full definition →	(0.05)	0.07	0.00	(0.08)
Research and Development Expense of Revenue Full definition →	5.65%	5.63%	6.06%	6.17%
Selling, General and Administrative Expense of Revenue Full definition →	17.95%	18.34%	17.97%	17.45%
Share Based Compensation of Revenue Full definition →	1.19%	1.14%	1.10%	1.06%
Interest Coverage Full definition →	2.14	2.00	1.83	1.63
Operating CF/Net income Full definition →	1.36	1.28	2.50	4.72
Depreciation/Fixed assets Full definition →	0.37	0.46	0.51	0.56
Capex/Depreciation Full definition →	(1.15)	(1.01)	(0.51)	(0.46)
Revenue per Share Full definition →	9.52	9.77	9.64	9.63
Operating CF per Share Full definition →	0.54	0.63	0.97	1.09
Capex per Share Full definition →	(0.72)	(0.67)	(0.37)	(0.36)
Capex to Sales Full definition →	0.08	0.07	0.04	0.04

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly